keyword
https://read.qxmd.com/read/38695464/speckle-tracking-incremental-role-in-diastolic-assessment-of-pediatric-patients-with-chronic-kidney-disease
#1
JOURNAL ARTICLE
Flora Maciel Penachio, Maria de Fátima Rodrigues Diniz, Rosana Sbruzzi Prado Laurino, Andreia Watanabe, Karen Saori Shiraishi Sawamura, Alessandro Cavalcanti Lianza, Carolina Rocha Brito Menezes, Isabela de Sousa Lobo Silva, Gabriela Nunes Leal
BACKGROUND: Cardiovascular complications are the leading cause of mortality in pediatric patients with chronic kidney disease (CKD). Echocardiographic assessment of diastolic function in CKD has been limited to spectral and tissue Doppler imaging, known to be less reliable techniques in pediatrics. Two-dimensional Speckle tracking echocardiography (2DST) derived left atrial (LA) strain has recently been confirmed as a robust measure of diastolic function. OBJECTIVES: To investigate LA strain role in diastolic assessment of children at different stages of CKD...
2024: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/38690659/ertugliflozin-for-functional-mitral-regurgitation-associated-with-heart-failure-effort-trial
#2
JOURNAL ARTICLE
Duk-Hyun Kang, Sung-Ji Park, Sung-Hee Shin, In-Chang Hwang, Yeonyee Elizabeth Yoon, Hyung-Kwan Kim, Mijin Kim, Min-Seok Kim, Sung-Cheol Yun, Jong-Min Song, Seok-Min Kang
BACKGROUND: The morbidity and mortality rates of patients with heart failure (HF) and functional mitral regurgitation (MR) remain substantial despite guideline-directed medical therapy for HF. We evaluated the efficacy of ertugliflozin for reduction of functional MR associated with HF with mild to moderately reduced ejection fraction. METHODS: The EFFORT trial (Ertugliflozin for Functional Mitral Regurgitation) was a multicenter, double-blind, randomized trial to examine the hypothesis that the sodium-glucose cotransporter 2 inhibitor ertugliflozin is effective for improving MR in patients with HF with New York Heart Association functional class II or III, 35%≤ejection fraction<50%, and effective regurgitant orifice area of chronic functional MR >0...
May 1, 2024: Circulation
https://read.qxmd.com/read/38689889/the-prognostic-value-of-serum-%C3%AE-klotho-in-age-related-diseases-among-the-us-population-a-prospective-population-based-cohort-study
#3
JOURNAL ARTICLE
Zhiwen Yang, Yusheng Ma, Yanbing Wang, Ming Jin, Jianping Bin, Zhiyong Chen, Zhonghua Teng
OBJECTIVE: α-Klotho is a potential biological marker of aging with satisfactory clinical applicability. However, its prognostic significance in age-related diseases has largely been undermined. Therefore, we aimed to report the prognostic value of serum α-klotho levels in age-related diseases. METHODS: Participants with available serum α-klotho data from the National Health and Nutrition Examination Survey (2007-2016) were included. Their survival status was collected at 7...
June 2024: Preventive Medicine Reports
https://read.qxmd.com/read/38687863/study-on-the-influence-of-management-style-based-on-the-hope-model-on-grace-score-lvef-and-quality-of-life-of-patients-with-myocardial-infarction
#4
JOURNAL ARTICLE
Yan Li, Yu Wang
OBJECTIVE: Myocardial infarction, coronary heart disease is one of the serious types, come on urgent, case fatality rate is high, especially the front wall or extensive anterior wall myocardial infarction, easy to merge cardiac insufficiency, arrhythmia, even in patients with sudden death will happen, and life-threatening. The aim of this study was to investigate the effects of HOPE management mode on cardiac function, quality of life and in-hospital cardiovascular adverse events in patients with myocardial infarction...
April 26, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38686682/quadricuspid-aortic-valve-imaging-diagnosis-and-prognosis
#5
JOURNAL ARTICLE
Mohammad Alomari, Magdy M El-Sayed Ahmed, Mostafa Ali, Ishaq J Wadiwala, Si M Pham, Basar Sareyyupoglu
Quadricuspid aortic valve is a rare congenital cardiac anomaly with an incidence of 0.008% to 0.043%. Its clinical course varies depending on cusp anatomy, function, and associated cardiac malformations. It frequently progresses to aortic valve regurgitation that may require surgical valve replacement. Detection has shifted from incidental discovery during autopsies or cardiac surgeries in the early 20th century to various cardiac imaging methods in recent decades. In addition to contributing to the literature, this report supports the use of transesophageal echocardiography more liberally to detect aortic valve abnormalities...
April 30, 2024: Texas Heart Institute Journal
https://read.qxmd.com/read/38682713/mortality-and-heart-failure-admission-after-mitral-valve-surgery-for-mitral-regurgitation-in-patients-with-versus-without-a-history-of-atrial-fibrillation-a-nationwide-study
#6
JOURNAL ARTICLE
Hans T Due, Jeppe K Petersen, Eva Havers-Borgersen, Daniel E Meulengracht, Lucas Grove Vejlstrup Bager, Lars Køber, Emil Fosbøl, Lauge Østergaard
This study aimed to examine the associated rate of 3-year mortality and heart failure (HF) admission in patients who underwent mitral valve replacement/repair (MVR) for mitral regurgitation (MR) with and without a history of atrial fibrillation (AF). Using Danish nationwide registries, we categorized adult patients who underwent MVR for MR from 2000 to 2018 according to history of AF. The cumulative incidence of all-cause mortality and HF admission with a maximum of 3 years of follow-up were examined using Kaplan-Meier and the Aalen Johansen estimator, respectively...
January 1, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38681325/reversing-the-tide-a-case-of-a-mechanical-aortic-valve-recipient-lost-to-follow-up-education-on-rivaroxaban-contraindications-and-the-vital-role-of-acenocoumarol-in-preventing-valve-thrombosis
#7
Hasan Kazma, Malak Fakih, Aalaa A Saleh, Yara Tarhini, Malek Mohammed
Aortic stenosis is the most common heart valve disease, especially among the elderly. Symptomatic aortic valve stenosis is linked to a poor prognosis and a high mortality rate if left untreated. The only effective treatment for severe symptomatic aortic stenosis is aortic valve replacement using either a mechanical or a biological prosthesis. Mechanical valve prostheses, while highly durable, are thrombogenic, necessitating lifelong anticoagulation with oral anti-vitamin K agents, such as acenocoumarol. Conversely, bioprosthetic valves, though less durable, carry a minimal thrombogenic risk and do not require anticoagulation...
March 2024: Curēus
https://read.qxmd.com/read/38680081/acute-mitral-valve-regurgitation-caused-by-left-ventricular-pacing-wire-during-transcatheter-aortic-valve-replacement
#8
JOURNAL ARTICLE
Byeng-Ju Son, Ung Kim, Jong-Ho Nam, Kang-Un Choi, Jong-Il Park, Jang-Won Son
Transcatheter aortic valve replacement is quickly becoming the standard of care for patients with severe aortic stenosis thanks to its minimally invasive nature and favorable outcomes. Recently, left ventricular pacing has been proposed as a safer alternative to traditional right heart pacing, which could simplify the transcatheter aortic valve replacement procedure overall, although procedural complications may still occur. This report describes a rare case of left ventricular pacing wire-induced acute severe mitral valve regurgitation during transcatheter aortic valve replacement...
April 29, 2024: Texas Heart Institute Journal
https://read.qxmd.com/read/38678022/individualized-prevention-of-proton-pump-inhibitor-related-adverse-events-by-risk-stratification
#9
JOURNAL ARTICLE
Bin Xia, Qiangsheng He, Fang Gao Smith, V Georgios Gkoutos, Krishnarajah Nirantharakumar, Zi Chong Kuo, Danni Wang, Qi Feng, Eddie C Cheung, Lunzhi Dai, Junjie Huang, Yuanyuan Yu, Wenbo Meng, Xiwen Qin, Jinqiu Yuan
Proton pump inhibitors (PPIs) are commonly used for gastric acid-related disorders, but their safety profile and risk stratification for high-burden diseases need further investigation. Analyzing over 2 million participants from five prospective cohorts from the US, the UK, and China, we found that PPI use correlated with increased risk of 15 leading global diseases, such as ischemic heart disease, diabetes, respiratory infections, and chronic kidney disease. These associations showed dose-response relationships and consistency across different PPI types...
April 27, 2024: Nature Communications
https://read.qxmd.com/read/38672777/comparative-effectiveness-of-complex-telemedicine-support-in-prevention-of-hospitalizations-and-mortality-in-patients-with-heart-failure-a-systematic-review-and-meta-analysis
#10
REVIEW
Andrey Garanin, Anatoly Rubanenko, Yuriy Trusov, Olesya Rubanenko, Alexandr Kolsanov
UNLABELLED: Heart failure is one of the leading causes of hospitalizations and mortality all over the world. There are literature data about the favorable influence of telemedicine support on mortality and hospitalization rate in patients with heart failure, and thus, the results of different studies are controversial. AIM: To estimate the effect of telemedicine support on hospitalization and mortality in patients with heart failure. METHODS: The literature search was conducted in databases Google Scholar, MedLine, Clinical Trials, PubMed, Embase, and Crossref with the following key words: "heart failure", "telemedicine", "telemonitoring", "hospitalisation (hospitalization)", "mortality"...
April 15, 2024: Life
https://read.qxmd.com/read/38670161/oxytocin-and-women-s-health-in-midlife
#11
REVIEW
Galit Levi Dunietz, Lucas J Tittle, Sunni L Mumford, Louise M O'Brien, Ana Baylin, Enrique F Schisterman, Ronald D Chervin, Larry J Young
Menopause marks the cessation of fertility and the transition to post-reproductive years. Nearly 1M US women experience menopause annually, but despite the significant impact it has on their physical and mental health, menopause has been insufficiently studied. Oxytocin is a neurohormone that regulates emotionality, social behaviors, and fundamental physiological systems. Localization of oxytocin receptors in the brain, reproductive tissues, bone, and heart support their role in mental health and potentially sleep, along with reproductive and cardiovascular functions...
April 1, 2024: Journal of Endocrinology
https://read.qxmd.com/read/38669640/a-novel-model-for-xenograft-right-ventricle-to-pulmonary-artery-conduit
#12
JOURNAL ARTICLE
Chace B Mitchell, Luke M Wiggins, Winfield J Wells, David C Cleveland, John D Cleveland
The last 40 years have shown dramatic improvement in outcomes for neonatal cardiac surgery for a spectrum of congenital heart disease diagnoses. With more patients surviving into adulthood, the long-term impact of initial management strategies of these patients has come into focus. This is particularly true for patients with pediatric heart valve disease. Many patients born with right ventricular to pulmonary artery (RVPA) discontinuity require placement of a valved conduit in the neonatal period. Valved conduit options are limited in this patient population due to patient size and inability to respond to somatic growth...
April 18, 2024: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
https://read.qxmd.com/read/38668703/understanding-changes-in-echocardiographic-parameters-at-different-ages-following-fetal-growth-restriction-a-systematic-review-and-meta-analysis
#13
REVIEW
Mette van de Meent, Kirsten T Nijholt, Shary C A Joemmanbaks, Judith Kooiman, Henk S Schipper, Kim E Wever, A Titia Lely, Fieke Terstappen
Fetal growth restriction (FGR) increases cardiovascular risk by cardiac remodeling and programming. This systematic review and meta-analysis across species examines the use of echocardiography in FGR offspring at different ages. PubMed and Embase.com were searched for animal and human studies reporting on echocardiographic parameters in placental insufficiency-induced FGR offspring. We included 6 animal and 49 human studies. While unable to perform a meta-analysis of animal studies due to insufficient number of studies per individual outcome, all studies showed left ventricular dysfunction...
April 26, 2024: American Journal of Physiology. Heart and Circulatory Physiology
https://read.qxmd.com/read/38668411/the-effect-of-a-subsequent-dose-of-dexmedetomidine-or-other-sedatives-following-an-initial-dose-of-dexmedetomidine-on-electrolytes-acid-base-balance-creatinine-glucose-and-cardiac-troponin-i-in-cats-part-ii
#14
JOURNAL ARTICLE
Chrysoula Margeti, Georgios Kazakos, Apostolos D Galatos, Vassilis Skampardonis, Theodora Zacharopoulou, Vassiliki Tsioli, Panagiota Tyrnenopoulou, Epameinondas Loukopoulos, Vasileios G Papatsiros, Eugenia Flouraki
The administered dose of dexmedetomidine may occasionally fail to produce the anticipated sedative effects. Therefore, a subsequent dose or administration of another sedative may enhance sedation; however, patient safety may be affected. The safety of seven different drugs administered at the following time point after an insufficient dose of dexmedetomidine was evaluated in a crossover, blind, experimental study that included six healthy adult cats. All cats received an initial dose of dexmedetomidine and a subsequent dose of either dexmedetomidine (Group DD), NS 0...
March 22, 2024: Veterinary Sciences
https://read.qxmd.com/read/38666776/sglt-2-inhibitors-focus-on-dapagliflozin
#15
JOURNAL ARTICLE
Zoya Siddiqui, Somar Hadid, William H Frishman
Dapagliflozin (trade name FARXIGA) is a sodium-glucose cotransporter-2 (SGLT-2) inhibitor that has transcended its initial antidiabetic application to demonstrate benefits in cardiac and renal diseases. It was first approved by the food and department administration for type 2 diabetes in 2014. Since then, it has gained food and department administration approval for chronic kidney disease in 2021, heart failure with reduced ejection fraction in 2020, and heart failure with preserved ejection fraction in 2023...
April 26, 2024: Cardiology in Review
https://read.qxmd.com/read/38665003/mitral-valve-regurgitation-in-klippel-feil-syndrome-with-related-thoracic-deformity
#16
JOURNAL ARTICLE
Yuki Endo, Yoshiei Shimamura, Hiroshi Niinami
Klippel-Feil syndrome, characterized by congenital fusion of any 2 or more cervical vertebrae, is a rare disorder in which skeletal and other organ system-related abnormalities have been reported. This article reports a case of mitral valve regurgitation in a patient with Klippel-Feil syndrome and related thoracic deformity who underwent mitral valvuloplasty. Postoperatively, the mitral valve regurgitation disappeared, and there has been no recurrence for 3 years. This case highlights mitral valvuloplasty via median sternotomy as an excellent treatment for mitral valve regurgitation in a patient with thoracic deformity related to Klippel-Feil syndrome...
April 26, 2024: Texas Heart Institute Journal
https://read.qxmd.com/read/38664980/comparison-between-beta-blockers-and-calcium-channel-blockers-in-patients-with-atrial-fibrillation-according-to-renal-function
#17
COMPARATIVE STUDY
José Antonio Parada Barcia, Sergio Raposeiras Roubin, David González Fernández, André González García, Carla Iglesias Otero, Inmaculada González Bermúdez, Andrés Íñiguez Romo, Emad Abu-Assi
BACKGROUND: Rate control is the most commonly employed first-line management strategy for atrial fibrillation (AF) in patients with chronic kidney disease (CKD). Principal agents used to control heart rate (HR) include beta-blockers (BB) and nondihydropyridine calcium channel blockers (ND-CCB). However, there is a paucity of published studies of the differences between those drugs in CKD patients. HYPOTHESIS: The present study aimed to investigate the differences, in terms of hospitalizations due to a poor HR control, in patients with AF under a rate-control strategy according to glomerular filtration rate (GFR)...
May 2024: Clinical Cardiology
https://read.qxmd.com/read/38664125/unused-potential-of-lipid-lowering-therapy-in-very-high-risk-patients-with-atherosclerotic-cardiovascular-disease-a-retrospective-data-analysis
#18
JOURNAL ARTICLE
Sarah B Pohl, Christiane Engelbertz, Holger Reinecke, Nasser M Malyar, Matthias Meyborg, Tobias J Brix, Julian Varghese, Katrin Gebauer
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) is the most common cause of death in Europe. Although the 2019 European Society of Cardiology/European Atherosclerosis Society Guidelines for the management of dyslipidaemias claim a target low-density lipoprotein cholesterol (LDL-C) value of <55 mg/dL for very high-risk patients by use of lipid-lowering therapy (LLT) and lifestyle adaptations, the target level achievement is not satisfactory. We examined LLT use in ASCVD patients exceeding LDL-C target levels at admission and its adaptations at discharge...
March 11, 2024: Nutrition, Metabolism, and Cardiovascular Diseases: NMCD
https://read.qxmd.com/read/38663467/correlation-of-cervical-inspiratory-muscle-electromyography-and-oxygen-uptake-during-treadmill-walkingcorrelation-of-cervical-inspiratory-muscle-electromyography-and-oxygen-uptake
#19
JOURNAL ARTICLE
Kenta Kawamura, Kazumichi Ae, Rinri Uematsu, Kazuto Yamaguchi, Kazuhide Tomita
For measurements of exercise intensity, an individual's oxygen uptake (V̇O2 ) is measured with an exhaled gas analyzer that involves a mask, but exercise coaching would benefit if an individual's V̇O2 could be estimated with more easily obtained predictors. We investigated the predictability of V̇O2 by electromyography (EMG) of the neck inspiratory muscles. We analyzed the EMG results of the sternocleidomastoid (EMGst) and scalene (EMGsc) muscles of 14 healthy adults who performed a treadmill exercise load test...
April 23, 2024: Respiratory Physiology & Neurobiology
https://read.qxmd.com/read/38660790/the-tricuspid-valve-a-review-of-pathology-imaging-and-current-treatment-options-a-scientific-statement-from-the-american-heart-association
#20
REVIEW
Laura J Davidson, Gilbert H L Tang, Edwin C Ho, Marat Fudim, Tiberio Frisoli, Anton Camaj, Margaret T Bowers, Sofia Carolina Masri, Pavan Atluri, Joanna Chikwe, Peter J Mason, Jason C Kovacic, George D Dangas
Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their disease course with severe right-sided heart failure, pulmonary hypertension, and life-limiting symptoms that have few durable treatment options. Traditionally, the only treatment for tricuspid valve disease has been medical therapy or surgery; however, there have been increasing interest and success with the use of transcatheter tricuspid valve therapies over the past several years to treat patients with previously limited therapeutic options...
April 25, 2024: Circulation
keyword
keyword
35086
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.